Print

ZymoGenetics, Inc. (ZGEN) Kidney Disease Drug Study Stopped  
10/28/2008 7:24:42 AM

Shares in ZymoGenetics Inc. fell more than 28 percent in Monday trading after the Seattle biotech announced that a test of one of its drugs targeted at kidney disease has been discontinued.
//-->